Trevena Inc. (TRVN) Kompaniya qiymatining sof foydaga nisbati
Trevena, Inc. (TRVN) klinikalarga yetkazib berish zanjiridagi uzilishlarni minimallashtiradigan maxsus dori vositalari uchun xavfsiz yetkazib berish tizimini yaratdi. Ushbu narx harakati joriy -0.10 ko'rsatkichini aks ettiradi. Kompaniya qaramlikni bartaraf etish uchun selektiv retseptorlarni maqsadli yo'naltirish orqali og'riqni boshqarish terapiyalarini ishlab chiqadi. Biznes avtonom ishlab chiqarish sikliga tayanadi, bu esa uni global inqirozlarga chidamli qiladi va ishonchli defensiv aktivga aylantiradi.
%20P%2FE%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwczyyub.rjb-7czcsu8&start=20220704&end=20261112&filename=GURU_Markets_-_TRVN_-_Trevena-Inc._-_PE-Multiple "TRVN: trevena.com Kapitalizatsiyaning foydaga nisbati 04.07.2022 - 12.10.2024 | 👁️GURU.Markets👁️")
Trevena, Inc. kompaniyasining tahliliy kesimlari
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi tafsilotlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Qarzning kapitalga nisbati Trevena, Inc.|TRVN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi Trevena Inc|TRVN - Kompaniyaning jamlangan qarzlari|Balans kapitallashuviga qarzlar Trevena, Inc.|TRVN - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli kredit va qarzlari Trevena|Oraliq qoplama koeffitsiyenti trevena.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
TRVN - Kompaniyaning sof foydasi|Sof foyda prognozi Trevena, Inc.|TRVN - P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati Trevena Inc.|TRVN - Narx-foyda va o‘sish multiplikatori|Kompaniyaning to‘liq qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Trevena, Inc.|TRVN - Eskirish chegirilmasdan oldingi operatsion foyda|So'nggi to'rtta chorak uchun bir aksiya uchun foyda Trevena|TRVN - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi trevena.com|TRVN - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi Trevena, Inc.
Kompaniyaning jamlanma tahlili:TRVN, trevena.com
Ushbu koeffitsient bozor kapitalizatsiyasining kompaniyaning sof foydasiga bo'linishi orqali hisoblanadi. Mazkur ko'rsatkich investitsiyalarning qoplanish muddatini aniqlab, aktiv uchun to'langan premiumning miqdorini aks ettiradi. Trevena, Inc. (TRVN) uchun ishlab chiqarishni ekologiyalashtirish va suvning yopiq siklda iste'mol qilinishi bilan bog'liq xarajatlar vaqtincha sof foydaga ta'sir ko'rsatmoqda. Kompaniya hisobotlariga asoslangan P/E ko'rsatkichini tahlil qilish orqali investor biznesning yetuklik darajasini baholaydi. Narxlar dinamikasi fundamental o'sishni spekulyativ vasvasadan ajratishga yordam beradi.
Raqobatdosh kompaniyalar
BIIB (biogen.com) - Bozor narxining sof foydaga nisbati|Narxning foydaga nisbati Neurocrine Biosciences, Inc. (NBIX)|RGC (Regencell Bioscience Ltd) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori AXSM (Axsome Therapeutics Inc)|ACADIA Corp (ACAD) - Kapitalizatsiyaning foydaga nisbati|XENE: Narx-foyda koeffitsiyenti|VKTX: Narxning foydaga nisbati|SUPN: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Catalyst Pharma (CPRX)|Narxning foydaga nisbati Denali Therapeutics Inc|Narx-foyda multiplikatori HRMY (Harmony Corp)|P/E multiplikatori BHVN|P/E multiplikatori amylyx.com (AMLX)|Trevi Therapeutics, Inc. - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati PRAX|Anavex Corp - P/E multiplikatori|Biznesning o‘zini qoplash muddati CeriBell EEG CBLL|prothena.com (PRTA) - Narxning foydaga nisbati|Narx-foyda multiplikatori ALEC|ANNX (Annexon) - P/E multiplikatori|Narx-foyda koeffitsiyenti Omeros Corp. (OMER)|Narx-foyda koeffitsiyenti NGNE (Neurogene Corp)|Biznesning o‘zini qoplash muddati AC Immune Inc|Voyager Therapeutics - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati NMRA (neumoratx.com)|SCLX - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati TVGN (Tevogen Bio Holdings Inc.)|ACOG (alphacognition.com) - Narx-foyda koeffitsiyenti|CGTX (Cognition Therapeutics Inc.) - Narxning foydaga nisbati|Narxning foydaga nisbati Inhibikase Therapeutics|Narx-foyda multiplikatori SAVA (cassavasciences.com)|Narxning foydaga nisbati Assertio Holdings, Inc. (ASRT)|coyatherapeutics.com - Narx-foyda multiplikatori|P/E multiplikatori VTGN (Vistagen)|Ovid Therapeutics Inc (OVID) - Kapitalizatsiyaning foydaga nisbati|ABOS: Narx-foyda koeffitsiyenti|CRVO - P/E multiplikatori|alteritytherapeutics.com (ATHE) - Narxning foydaga nisbati|Clene - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati PepGen Inc|Kapitalizatsiyaning foydaga nisbati Jupiter Neurosciences, Inc. JUNS|Narx-foyda koeffitsiyenti RLMD (Relmada Therapeutics)|Bozor narxining sof foydaga nisbati ANVS|Narxning foydaga nisbati Grace Therapeutics GRCE|Kompaniya qiymatining sof foydaga nisbati AIFF|ANEW Medical, Inc. - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati NeuroSense Therapeutics|RVPH (Reviva Pharmaceuticals) - Narx-foyda koeffitsiyenti|MTVA (MetaVia) - Narxning foydaga nisbati|NRXS (NeurAxis) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Helius Medical Technologies Inc. HSDT|Narxning foydaga nisbati Passage Bio, Inc. (PASG)|bionomics.com.au - Narx-foyda multiplikatori|P/E multiplikatori NERV (Minerva Neurosciences)|P/E multiplikatori athira.com ATHA|ADXN: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati ALZN (Alzamend Neuro, Inc.)|CYCN: P/E multiplikatori|PTIX - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Pasithea Therapeutics Corp|Narx-foyda multiplikatori CRGT (Cortigent Medical)|P/E multiplikatori ATXI|Narx-foyda koeffitsiyenti Brainstorm Cell Therapeutics Inc. BCLI|Cara Therapeutics, Inc - Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati Chromocell (CHRO)|ELYM: Narx-foyda koeffitsiyenti|Intra-Cellular Therapies - Bozor narxining sof foydaga nisbati|Longboard Pharmaceuticals, Inc. (LBPH) - Narxning foydaga nisbati|Marinus Pharmaceuticals Inc - Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti NKGN|Narxning foydaga nisbati NRBO|Narxning foydaga nisbati Sage Therapeutics, Inc. (SAGE)|synaptogen.com - Narx-foyda multiplikatori|Narxning foydaga nisbati Vigil Neuroscience, Inc. VIGL|WENA: Narx-foyda multiplikatori|Cerevel - P/E multiplikatori
